Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: An in vivo study

Liver International

Volumn 26, Issue 7, 2006, Pages 889-898

  Geerts, Anja M ^a   De Vriese, An S ^a   Vanheule, Eline ^a   Van Vlierberghe, Hans ^a   Mortier, Siska ^a   Cheung, Kin Jip ^a   Demetter, Pieter ^a   Lameire, Norbert ^a   De Vos, Martine ^a   Colle, Isabelle ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Angiogenesis; Cirrhosis; Endothelial nitric oxide synthase; Intravital microscopy; Portal hypertension; Vascular endothelial growth factor

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; COMMON BILE DUCT; CONTROLLED STUDY; CORRELATION ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CIRRHOSIS; MALE; MESENTERY BLOOD VESSEL; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PATHOLOGICAL ANATOMY; PORTAL HYPERTENSION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION; VEIN LIGATION;

ANIMALS; CAPILLARY PERMEABILITY; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MESENTERY; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PORTAL VEIN; RATS; RATS, WISTAR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33746704304     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01308.x     Document Type: Article

References (28)

1. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 1991; 337: 776-8.
2. Perez-Ruiz M, Ros J, Morales-Ruiz M, et al. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide. Hepatology 1999; 29: 1057-63.
3. Sumanovski L T, Battegay E, Stumm M, van der Kooij M, Sieber C C. Increased angiogenesis in portal hypertensive rats: Role of nitric oxide. Hepatology 1999; 29: 1044-9.
4. Sieber C C, Sumanovski L T, Stumm M, van der Kooij M, Battegay E. In vivo angiogenesis in normal and portal hypertensive rats: Role of basic fibroblast growth factor and nitric oxide. J Hepatol 2001; 34: 644-50.
5. Cejudo-Martin P, Ros J, Navasa M, et al. Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2001; 34: 487-93.
6. Fernandez M, Vizzutti F, Garcia-Pagan J C, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 2004; 126: 886-94.
7. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan J C, Rodes J, Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 2005; 43: 98-103.
8. Carmeliet P, Jain R K. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
9. Rosmorduc O, Wendum D, Corpechot C, et al. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 1999; 155: 1065-73.
10. Corpechot C, Barbu V, Wendum D, et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002; 35: 1010-21.
11. Fukumura D, Gohongi T, Kadambi A, et al. Predominant role of endothelial nitric oxide in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001; 98: 2604-9.
12. Ziche M, Morbidelli L, Masini E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by susbstance P. J Clin Invest 1994; 94: 2036-44.
13. Ziche M, Morbidelli L, Choudhuri R, Zhang H, Donnini S, Granger H J. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-34.
14. Ohara N, Voelkel N F Chang S W. Tissue eicosanoids and vascular permeability in rats with chronic biliary obstruction. Hepatology 1993; 18: 111-8.
15. Wirth K J, Bickel M, Hropot M, et al. The bradykinin B2 receptor antagonist Icatibant (HOE 140) corrects avid Na+ retention in rats with CCl4-induced liver cirrhosis: Possible role of enhanced microvascular leakage. Eur J Pharmacol 1997; 337: 45-53.
16. Colle I, De Vriese A, Van Vlierberghe H, Lameire N, De Vos M. Vascular hyporesponsiveness in the mesenteric artery of rats with cirrhosis and portal hypertension: An in vivo study. Eur J Gastroenterol Hepatol 2004; 16: 139-45.
17. Colle I, De Vriese A, Van Vlierberghe H, Lameire N, De Vos M Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis, support for a risk in cirrhotic patients. Liver Int 2004; 24: 63-8.
18. De Vriese A S Lameire N H. Intravital microscopy: An integrated evaluation of peritoneal function and structure. Nephrol Dial Transplant 2001; 16: 657-60.
19. De Vriese A S, Tilton R G, Stephan C C Lameire N H. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001; 12: 1734-41.
20. Mortier S, Faict D, Lameire N H De Vriese A S. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 2005; 67: 1559-65.
21. Mortier S, Faict D, Schalkwijk C G, Lameire N H De Vriese A S. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int 2004; 66: 1257-65.
22. Garcia-Pagan J C, Fernandez M, Bernadich C, et al. Effect of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. Am J Physiol Gastrointest Liver Physiol 1994; 267: G984-90.
23. Theodorakis N G, Wang Y, Skill N J, et al. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: Studies in gene-knockout mice. Gastroenterology 2003; 124: 1500-8.
24. Koshy A, Gottardi A D Ledermann M, et al. Endothelial nitric oxide synthase is not essential for the development of fibrosis and portal hypertension in bile duct ligated mice. Liver Int 2005; 25: 1044-52.
25. Niederberger M, Gines P, Martin P Y, et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 1996; 24: 947-51.
26. Tazi K A, Barriere E, Moreau R, et al. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. Gastroenterology 2002; 122: 1869-77.
27. Lee P C, Salapongse A N, Bragdon G A, Shears L L, Watkins S C Edington H D. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999; 277: H1600-8.
28. Zhao L X, Lu X, Feng O. Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis. Am J Physiol Heart Circ Physiol 2002; 283: H2371-8.